During the past decade, University of Miami Division of Clinical Pharmacology conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 5 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 5 clinical trials were completed. i.e. 55.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Miami Division of Clinical Pharmacology" #1 sponsor was "Pfizer" with 10 trials, followed by "Wockhardt" with 3 trials sponsored, "PTC Therapeutics" with 2 trials sponsored, "Allergan" with 1 trials sponsored and "Entasis Therapeutics" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Miami Division of Clinical Pharmacology" #1 collaborator was "Clinartis" with 2 trials as a collaborator, "Syneos Health" with 1 trials as a collaborator and "University of Miami" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "University of Miami Division of Clinical Pharmacology" are "Renal Impairment" (9 trials), "Hepatic Impairment" (7 trials), "Healthy Volunteers" (2 trials), "Acinetobacter Baumannii Infection" (1 trials) and "Healthy Participants" (1 trials). Many other conditions were trialed in "University of Miami Division of Clinical Pharmacology" in a lesser frequency.

Most popular intervention types in "University of Miami Division of Clinical Pharmacology" are "Drug" (21 trials). Other intervention types were less common.

The name of intervention was led by "Deflazacort" (2 trials), "Cefepime and Tazobactam combination" (1 trials), "Dacomitinib" (1 trials), "ETX2514SUL" (1 trials) and "Elafibranor" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Miami Division of Clinical Pharmacology" are 20 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "University of Miami Division of Clinical Pharmacology". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in University of Miami Division of Clinical Pharmacology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of Miami Division of Clinical Pharmacology, 20 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".